970
Views
11
CrossRef citations to date
0
Altmetric
Research Articles

Microbubble-enhanced ultrasound-mediated gene transfer – Towards the development of targeted gene therapy for cancer

&
Pages 300-310 | Received 10 Nov 2011, Accepted 16 Jan 2012, Published online: 23 May 2012

References

  • Mingozzi F, High KA. Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges. Nature Rev Gen 2011; 12: 341–356
  • Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, Morillon E, et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 2008; 118: 3123–3142
  • Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, et al. LOM2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415–419
  • Andre FM, Mir LM. Nucleic acids electrotransfer in vivo: Mechanisms and practical aspects. Curr Gene Ther 2010; 10: 267–280
  • Cemazar M, Jarm T, Sersa G. Cancer electrogene therapy with interleukin-12. Curr Gene Ther 2010; 10: 300–311
  • Heller LC, Heller R. Electroporation gene therapy preclinical and clinical trials for melanoma. Curr Gene Ther 2010; 10: 312–317
  • Bodles-Brakhop AM, Heller R, Draghlia-Akli R. Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: Current clinical developments. Mol Ther 2009; 17: 585–592
  • Davalos RV, Otten DM, Mir LM, Rubinsky B. Electrical impedance tomography for imaging tissue electroporation. IEEE Trans Biomed Eng 2004; 51: 761–767
  • Coussios CC, Farny CH, ter Haar G, Roy RA. Role of acoustic cavitation in the delivery and monitoring of cancer treatment by high-intensity focused ultrasound (HIFU). Int J Hyperthermia 2007; 23: 105–120
  • Hynynen K. Hyperthermia classical commentary. Int J Hyperthermia 2010; 26: 12–15
  • Crouzet S, Murat FJ, Pasticier G, Cassier P, Chapelon JY, Gelet A. High intensity focused ultrasound (HIFU) for prostate cancer: Current clinical status, outcomes and future perspectives. Int J Hyperthermia 2010; 26: 796–803
  • McHale AP, Nomikou N, Brain tumours: Preclinical assessment of targeted, site-specific therapy exploiting ultrasound and cancer chemotherapeutic drugs. In: Hayat MA, eds. Tumours of the Central Nervous System, Volume 4. Springer Science+Business Media, 2012, pp. 313–322
  • Platts DG, Fraser JF. Contrast echocardiography in critical care: Echoes of the future? A review of the role of microsphere contrast echocardiography. Crit Care Resusc 2011; 13: 44–55
  • Cosgrove D, Lassau N. Imaging of perfusion using ultrasound. Eur J Nucl Med Mol Imaging 2010; 37: S65–S85
  • Pysz MA, Foygel K, Panje SM, Needles A, Tian L, Willmann JK. Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging. Invest Radiol 2011; 46: 187–195
  • Mandai M, Koda M, Matono T, Nagahara T, Sugihara T, Ueki M, et al. Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: Comparison with dynamic CT. Brit J Radiol 2011; 84: 499–507
  • Husseini GA, Diaz de la Rosa MA, Richardson ES, Christensen DA, Pitt WG. The role of cavitation in acoustically activated drug delivery. J Control Release 2005; 107: 253–261
  • Suslick KS. Sonochemistry. Science 1990; 23: 1439–1445
  • Nejad SM, Hamid S, Hosseini R, Akiyama H, Tachibana K. Optical observation of cell sonoporation with low intensity ultrasound. Biochem Biophys Res Comm 2011; 413: 218–223
  • Brayman AA, Coppage ML, Vaidya S, Miller MW. Transient poration and cell surface receptor removal from human lymphocytes in vitro by 1 MHz ultrasound. Ultrasound Med Biol 1999; 25: 999–1008
  • Miller MW. Gene transfection and drug delivery. Ultrasound Med Biol 2000; 26: S59–S62
  • Qin S, Caskey CF, Ferrara KW. Ultrasound contrast microbubbles in imaging and therapy: Physical principles and engineering. Phys Med Biol 2009; 54: R27–R57
  • Porter TR, Iversen PL, Li S, Xie F. Interaction of diagnostic ultrasound with synthetic oligonucleotide-labelled perfluorocarbon-exposed sonicated dextrose albumin microbubbles. J Ultrasound Med 1996; 15: 577–584
  • Unger EC, Hersh E, Vannan M, McCreery T. Gene delivery using ultrasound contrast agents. Echocardiography 2001; 18: 355–361
  • Nomikou N, McHale AP. Exploiting ultrasound-mediated effects in delivery targeted, site-specific cancer therapy. Cancer Lett 2010; 296: 133–143
  • Nomikou N, Tiwari P, Trehan T, Gulati K, McHale AP, Studies on neutral, cationic and biotinylated cationic microbubbles in enhancing ultrasound-mediated gene delivery in vitro and in vivo. Acta Biomater 2011;8:1273–1280
  • Houk BE, Hochhaus G, Hughes JA. Kinetic modeling of plasmid DNA degradation in rat plasma. AAPS Pharmsci 1999; 1: 1–6
  • Sboros V. Response of contrast agents to ultrasound. Adv Drug Delivery Rev 2008; 60: 1117–1136
  • Sheyn D, Kimelman-Bleich N, Pelled G, Zilberman Y, Gazit D, Gazit Z. Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Ther 2008; 15: 257–266
  • Lemmon JC, Mcfarland RJ, Rybicka JM, Balce DR, McKeown KR, Krohn RM, et al. In vitro and in vivo transfection of primary phagocytes via microbubble-mediated intraphagosomal sonoporation. J Immunol Methods 2011; 31: 152–158
  • Sakai T, Kawaquchi M, Kosuge Y. siRNA-mediated gene silencing in the salivary gland using in vivo microbubble-enhanced sonoporation. Oral Dis 2009; 15: 505–511
  • Kawalczuk L, Boudinet M, El Sanharawi M, Touchard E, Naud MC, Saied A, et al. In vivo gene transfer into the ocular ciliary muscle mediated by ultrasound and microbubbles. Ultrasound Med Biol 2011; 37: 1814–1827
  • Alter J, Sennoga CA, Lopes DM, Eckersley RJ, Wells DJ. Microbubble stability is a major determinant of the efficiency of ultrasound and microbubble mediated in vivo gene transfer. Ultrasound Med Biol 2009; 35: 976–984
  • Yoon CS, Jung HS, Kwon MJ, Lee SH, Jim CW, Kim MK, et al. Sonoporation of the minicircle-VEGF (165) for wound healing of diabetic mice. Pharm Res 2009; 26: 794–801
  • Taniyama Y, Tachibana K, Hiraoka K, Namba T, Yamasaki K, Hashiya N, et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002; 105: 1233–1239
  • Ohta S, Suzuki K, Tachibana K, Yamada G. Microbubble-enhanced sonoporation: Efficient gene transduction technique for chick embryos. Genesis 2003; 37: 91–101
  • Gaspar VM, Correia IJ, Sousa A, Silva F, Paquete CA, Queiroz JA, Sousa F, Nanoparticle mediated delivery of pure p53 supercoiled plasmid DNA for gene therapy. J Control Release 2011;156:212–222
  • Zhang YA, Nemunaitis J, Samuel SK, Chen P, Shen Y, Tong AW. Antitumour activity of an oncolytic adenovirus-delivered oncogene small interfering RNA. Cancer Res 2006; 66: 9736–9743
  • Won YW, Kim KM, An SS, Lee M, Ha Y, Kim YH. Suicide gene therapy using reducible poly (oligo-D-arginine) for the treatment of spinal cord tumors. Biomaterials 2011; 32: 9766–9755
  • Zhu S, Lee AD, Li S. IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. J Immunol 2010; 184: 2348–2354
  • Belur LR, Podetz-Pedersen KM, Sorenson B, Hsu AH, Parker JB, Carlson CS, et al. Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty transposon system. Molecular Cancer 2011; 10: 14–26
  • Yamaguchi K, Feril LB, Tachibana K, Takahashi A, Matsuo M, Endo H, et al. Ultrasound-mediated interferon β gene transfection inhibits growth of malignant melanoma. Biochem Biophys Res Comm 2011; 411: 137–142
  • Tsai KC, Liao ZH, Lin WL, Shieh MJ, Hwang LH, Chen WS. Antiangiogenic gene therapy on hepatocellular carcinoma using endostatin. Biomed Eng 2011; 22: 71–79
  • Li YS, Davidson E, Reid CN, McHale AP. Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: Potential applications for gene therapy of cancer. Cancer Lett 2009; 273: 62–69
  • Suzuki R, Namai E, Oda Y, Nishiie N, Otake S, Koshima R, et al. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoural ultrasound exposure. J Control Release 2010; 142: 245–250
  • Carson AR, McTiernan CF, Lavery L, Hodnick A, Grata M, Leng X, et al. Gene therapy of carcinoma using ultrasound-triggered microbubble destruction. Ultrasound Med Biol 2011; 37: 393–402
  • Suzuki R, Takizawa T, Negishi Y, Utoguchi N, Sawamura K, Tanaka K, et al. Tumour specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles. J Control Release 2008; 125: 137–144
  • Chen ZY, Liang J, Qiu RX. Targeted gene delivery in tumor zenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit surviving gene expression and induce apoptosis. J Exp Clin Can Res 2010; 29: 152–161
  • Sirsi SR, Hernandez SL, Zielinski L, Blomback H, Koubaa A, Synder M, et al. Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. J Control Release 2012;157:224–234
  • Fan L, Liu Y, Ying H, Xue Y, Zhang Z, Wang P, et al. Increasing of blood–tumour barrier permeability through paracellular pathway by low frequency ultrasound irradiation in vitro. J Mol Neurosci 2011; 43: 541–548
  • Rainov NG. A phase III clinical evalulation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Human Gene Ther 2000; 11: 2389–2401
  • Furgeson DY, Yockman JW, Janat MM, Kim SW. Tumor efficacy and biodistribution of linear polyethylenimine-cholesterol/DNA complexes. Mol Ther 2004; 9: 837–845
  • Kircheis R, Schuller S, Brunner S, Ogris M, Heider KH, Zauner W, Wagner E. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J Gene Med 1999; 1: 111–120
  • Borden MA, Caskey CF, Little E, Gillies RJ, Ferrara KW. DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles. Langmuir 2007; 23: 9401–9408
  • Haag P, Frauscher F, Gradl J, Seitz A, Schafer G, Lindner JR, et al. Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. J Steroid Biochem Mol Biol 2006; 102: 103–113
  • Marcucci F, Corti A, How to improve exposure of tumor cells to drugs – Promoter drugs increase tumor uptake and penetration of effector drugs. Adv Drug Deliv Rev 2011; in press
  • Bekeredjian R, Kroll RD, Fein E, Tinkov S, Coester C, Winter G, et al. Ultrasound targeted microbubble destruction increases capillary permeability in hepatomas. Ultrasound Med Biol 2007; 33: 1592–1598
  • Bohmer MR, Chlon CHT, Raju BI, Chin CT, Shevchenko T, Klibanov AL. Focused ultrasound and microbubbles for enhanced extravasation. J Control Release 2010; 148: 18–24
  • Nomikou N, Li YS, McHale AP. Ultrasound-enhanced drug dispersion through solid tumours and its possible role in aiding ultrasound-targeted cancer chemotherapy. Cancer Lett 2010; 288: 94–98
  • Horie S, Watanabe Y, Ono M, Mori S, Kodama T. Evaluation of antitumor effects following tumor necrosis factor-α gene delivery using nanobubbles and ultrasound. Cancer Sci 2011; 102: 2082–2089
  • Rapoport NY, Kennedy AM, Shea JE, Scaife CL, Nan KH. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release 2009; 268–276

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.